Gram-positive pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007–23)
The CANWARD surveillance study has provided 17 years of reference antimicrobial susceptibility testing data on Gram-positive pathogens.
Authors
- Joseph M. Blondeau (ORCID: https://orcid.org/0000-0003-3396-0334)
- George R. Golding (ORCID: https://orcid.org/0000-0002-4285-4747)
- Christian Lavallée (ORCID: https://orcid.org/0000-0002-4249-8666)
- Alyssa Golden (ORCID: https://orcid.org/0000-0002-1788-1794)
- Heather J. Adam (ORCID: https://orcid.org/0000-0002-5646-6454)
- Melanie R. Baxter
- Philippe Lagacé‐Wiens (ORCID: https://orcid.org/0000-0002-5826-2869)
- Denice C. Bay (ORCID: https://orcid.org/0000-0002-3620-828X)
- James A. Karlowsky (ORCID: https://orcid.org/0000-0002-1939-464X)
- Frank Schweizer (ORCID: https://orcid.org/0000-0001-8697-5519)
- Andrew Walkty (ORCID: https://orcid.org/0000-0003-2880-2104)
- Susan M. Poutanen (ORCID: https://orcid.org/0000-0003-4747-2550)
- Melissa McCracken
- George G. Zhanel (ORCID: https://orcid.org/0000-0002-3238-0082)
- Ross Davidson (ORCID: https://orcid.org/0000-0001-5361-0038)
- Jeff Fuller
Institutions
- Western University (CA)
- Public Health Agency of Canada (CA)
- Queen Elizabeth II Health Sciences Centre (CA)
- Royal University Hospital (CA)
- Hôpital Maisonneuve-Rosemont (CA)
- Sinai Health System (CA)
- University of Manitoba (CA)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1093/jac/dkaf263
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- University of Manitoba
- Merck Canada
- Sandoz Canada